Navigation Links
ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt's Disease and Dry Age-Related Macular Degeneration
Date:6/16/2011

MARLBOROUGH, Mass., June 16, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The patients were enrolled at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA).

The Phase 1/2 trials are prospective, open-label studies primarily designed to determine the safety and tolerability of the RPE cells following sub-retinal transplantation into patients with SMD and Dry AMD. Each study will enroll 12 patients with cohorts of three patients in an ascending dosage format. The primary endpoint of both studies is to determine the safety and tolerability of hESC-derived RPE cells at 12 months.

"The enrollment of the first patients in our two clinical trials marks an important step forward for the field of regenerative medicine," said Gary Rabin, interim chairman and CEO of ACT. "We are very pleased with the progress that has been made toward bringing this ground-breaking technology to the patients who need it most.  If these therapies work as we hope they will, particularly with small volumes of cells, then we should be in an excellent position to take advantage of our patented techniques for manufacturing large numbers of doses of RPE cells that can be conveniently stored and shipped to clinicians following the basic manufacturing and distribution systems already familiar to pharmaceutical and biotech companies."

Principal investigator Steven Schwartz, M.D., Ahmanson Professor of Ophthalmology at the David Geffen School of Medicine at UCLA and retina division chief at the Jules Stein Eye Institute at UCLA, said, "These trials mark a significant step toward addressing what is on
'/>"/>

SOURCE Advanced Cell Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... 27, 2014 Research and Markets ... Palmitic Acid Industry Report 2014" report to their ... The Global Palmitic Acid Industry Report 2014 is ... of the global palmitic acid industry. The ... definitions, classifications, applications and industry chain structure. The palmitic ...
(Date:11/27/2014)... OXFORD, England , November 27, 2014 ... free online on ScienceDirect   Elsevier ... information products and solutions, is pleased to announce the ... Letters . The launch ... by the rapid advances at the forefront of applied ...
(Date:11/27/2014)... Washington, and PITTSFIELD, Massachusetts, USA (PRWEB) November 26, 2014 ... cancer cells with more accuracy, additive systems to enable ... highway safety by analyzing road conditions are among finalists ... for Photonics Innovation . The awards are sponsored by ... , and Photonics Media . , Winners will ...
(Date:11/26/2014)... The report on the Global Smart ... concerned market for revenue forecasts and market trends. It ... 51.9% from 2013 to 2018. At the projected rate, ... $1,415.6 million by 2018. , Browse through the Global ... information about the market segmentation and in-depth analysis supported ...
Breaking Biology Technology:Global Palmitic Acid Industry Report 2014 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4
... Faster. , ... Des Moines, Iowa (Vocus) November 6, 2008 -– DuPont ... Hermiston, Ore. The expansion is one of many steps DuPont business ... for Pioneer® brand products and help farmers meet the strong global demand ...
... Calif., Nov. 6 Frost & Sullivan ... of the Year Award in,molecular/cellular imaging has ... molecular platform for the targeting and imaging ... known as Aposense(R), is,an innovative set of ...
... 6 Morria Biopharmaceuticals,Plc, a biopharmaceutical company focused ... its ICH compliant Phase II equivalent,multi-center study of ... was given as an intranasal spray formulation., ... in allergic,rhinitis patients outside of the local allergy ...
Cached Biology Technology:DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain 2DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain 3Aposense Receives Frost & Sullivan Technology Innovation of the Year Award 2Aposense Receives Frost & Sullivan Technology Innovation of the Year Award 3Aposense Receives Frost & Sullivan Technology Innovation of the Year Award 4Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 2Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients 3
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
(Date:11/10/2014)... appearing on U.S. store shelves in early 2010, and ... The small packets can be tossed into a washing ... or powder. The convenience, though, has come with risks ... at Nationwide Children,s Hospital found that from 2012 through ... children younger than 6 years of age swallowing, inhaling, ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2
... available in French and German . ... College London. Scientists have been able to reconstruct, for ... of early tetrapods, the earliest four-legged animals. High-energy X-rays and ... the backbones of the 360 million year old fossils in ...
... hair and eye colour from modern forensic samples can also ... a new study published in BioMed Central,s open access journal ... able to reconstruct hair and eye colour from teeth up ... (1881 to 1943) confirming his blue eyes and blond hair. ...
... This press release is available in French and ... and the Royal Veterinary College London. Scientists have been ... structure of the backbone of early tetrapods, the earliest four-legged ... the researchers to reconstruct the backbones of the 360 million ...
Cached Biology News:Scientists reassemble the backbone of life with a particle accelerator 2Scientists reassemble the backbone of life with a particle accelerator 3Scientists reassemble the backbone of life with a particle acceleratorynchrotron X-rays 2Scientists reassemble the backbone of life with a particle acceleratorynchrotron X-rays 3
IKKbeta/IKK-2 Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Reacts with human. Tested in Western blotting....
... GeneRacer is an advanced RACE (rapid ... the efficiency of amplifying full-length 5' and ... available with SuperScript II Reverse Transcriptase (RT) ... end from long and complex mRNA. The ...
activating transcription factor 4 (tax-responsive enhancer element B67),...
2ndGen Predilute antibody for staining tissue sections. Optimized for use with Zymeds Histostain-PLUS, NBA, HistoST5050, and Cap-Plus IHC Kits.Labeling: ASR...
Biology Products: